Asset
BRINZOLAMIDE
Revenue
No revenue reported in loaded filings.
Clinical trials (14)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00767481 | phase3 | terminated | 2008-10-01 | 2009-02-01 | Alcon Research | 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT |
| NCT00326092 | phase2 | completed | 2006-05-01 | 2006-08-01 | Alcon Research | A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
| NCT00314171 | phase3 | completed | 2005-10-01 | 2007-08-01 | Alcon Research | A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
| NCT00314158 | phase3 | completed | 2005-11-01 | 2007-01-01 | Alcon Research | A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
| NCT01518244 | phase4 | completed | 2011-12-01 | 2013-02-01 | Alcon Research | Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 204251 | NDA | ALCON LABORATORIES INC |
Marketed products (1)
- SIMBRINZA